New Zealand markets closed

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
323.48+10.02 (+3.20%)
At close: 04:03PM EDT
324.60 +1.12 (+0.35%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
29,322,800
28,318,400
24,539,800
22,319,500
24,555,700
Cost of revenue
7,506,300
7,312,800
5,483,300
4,721,200
6,430,000
Gross profit
21,816,500
21,005,600
19,056,500
17,598,300
18,125,700
Operating expenses
Research development
6,963,900
7,025,900
6,085,700
5,595,000
5,307,100
Selling general and administrative
6,413,500
6,431,600
6,121,200
6,213,800
6,631,800
Total operating expenses
13,377,400
13,457,500
12,206,900
11,808,800
11,938,900
Operating income or loss
8,439,100
7,548,100
6,849,600
5,789,500
6,186,800
Interest expense
336,900
339,800
359,600
400,600
272,100
Total other income/expenses net
-1,396,400
-1,078,200
706,900
-203,400
-2,280,300
Income before tax
6,732,700
6,155,500
7,229,900
5,265,900
3,795,700
Income tax expense
603,400
573,800
1,036,200
628,000
563,700
Income from continuing operations
6,129,300
5,581,700
6,193,700
4,637,900
3,232,000
Net income
6,129,300
5,581,700
6,193,700
8,318,400
3,232,000
Net income available to common shareholders
6,129,300
5,581,700
6,193,700
8,318,400
3,232,000
Basic EPS
-
5.85
6.47
8.69
3.14
Diluted EPS
-
5.85
6.47
8.69
3.13
Basic average shares
-
953,653
956,590
957,526
1,027,721
Diluted average shares
-
953,653
956,590
957,526
1,033,667
EBITDA
-
8,042,900
8,913,400
6,899,100
5,676,800